Board certified by the American Board of Psychiatry and Neurology, Dr. Ash Bhatt, MD currently serves as chief medical officer at Sovereign Health Group. Having received his medical degree from Universidad Iberoamericana School of Medicine in Santo Domingo, Dominican Republic, Dr. Ash Bhatt is trained in managing mental health conditions with the psychopharmacological interventions, including Xanax.
Psychopharmacology is the practice of managing a patient’s psychological condition through the administration of medication. Clinicians practicing psychopharmacology have comprehensive understanding in polymorphic genes (the diversity of genes ranging from patient to patient), protein binding (availability of the medicine to the body), medical drug interaction (how the medication affects other medicines), and medication half-life (duration the medicine stays in the body).
Classified as a benzodiazepine, Xanax has been prescribed by clinicians to manage panic disorders and anxiety in patients for the past 35 years. Also known as alprazolam, the medication affects the brain and central nervous system by producing a calming effect for the patient. Enhancing the presence of the naturally produced hormone gama-amino butyric acid in the brain, the psychopharmacological use of Xanax may cause addiction and feelings of withdrawal.
Reported side effects commonly associated with the psychopharmacological administration of Xanax include dizziness, drowsiness, change in libido, and increased salivary secretion. Other serious side effects requiring immediate medical attention are trouble breathing, seizures, jaundice, hallucinations, slurred speech, loss of coordination, and thoughts of suicide.